Publications
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma2020 | Faculty of Medicine in Hradec Králové
- Herpes simplex virus resistant to acyclovir: A single-centre experience from the Czech Republic2019 | Faculty of Medicine in Hradec Králové
- The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients2018 | Faculty of Medicine in Hradec Králové
- COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status2017 | Faculty of Medicine in Hradec Králové
- Venous thromboembolism in patients with chronic lymphocytic leukemia2015 | Faculty of Medicine in Hradec Králové
- Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia2014 | Faculty of Medicine in Hradec Králové
- Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features2010 | Faculty of Medicine in Hradec Králové
- Clinical picture, diagnosis and differential diagnosis2010 | Faculty of Medicine in Hradec Králové
Loading network view...
